TriangleNCT02158975 · OUTCOME
Median Progression Free Survival Time
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- MEDIAN
- Unit
- months
- Interval / dispersion
- 95% Confidence Interval
- Time frame
- 24 months after initiation of study treatment
What was measured
Progression Free Survival (PFS) is defined as the time from study start until disease progression or death.
Analysis population: 5 of the 12 patients withdrew prior to progression and therefore progression free survival was censored at their time of withdraw.
Groups in this outcome
MLN9708
MLN9708 4mg by mouth weekly (days 1, 8, 15) every 28 days. MLN9708
| Group | Source count |
|---|---|
| MLN9708 | 12 |
Reported measurements
Source class 1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| MLN9708 | 3.2 | Not reported | 1.6 | NA | the upper limit was not reached |
Complete source fields
- classes
- categories
- measurements
- comment
- the upper limit was not reached
- group Id
- OG000
- lower Limit
- 1.6
- upper Limit
- NA
- value
- 3.2
- denoms
- counts
- group Id
- OG000
- value
- 12
- units
- Participants
- description
- Progression Free Survival (PFS) is defined as the time from study start until disease progression or death.
- dispersion Type
- 95% Confidence Interval
- groups
- description
- MLN9708 4mg by mouth weekly (days 1, 8, 15) every 28 days. MLN9708
- id
- OG000
- title
- MLN9708
- param Type
- MEDIAN
- population Description
- 5 of the 12 patients withdrew prior to progression and therefore progression free survival was censored at their time of withdraw.
- reporting Status
- POSTED
- time Frame
- 24 months after initiation of study treatment
- title
- Median Progression Free Survival Time
- type
- SECONDARY
- unit Of Measure
- months
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice